Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures — Hisashi Hidaka (2018) | RDL Network
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
Article 2018 en
Authors
HH
Hisashi Hidaka
MK
Masayuki Kurosaki
HT
Hironori Tanaka
Abstract
1 min read
In a placebo-controlled trial, lusutrombopag was effective in achieving and maintaining the target platelet count in patients with chronic liver disease and thrombocytopenia undergoing invasive procedures. No significant safety concerns were raised. Japanese clinical trial registration no: JapicCTI-132323.
Alexandre Joosten, Shalini Raj Lawrence, Alexandra Colesnicenco, Sean Coeckelenbergh, Jean Louis Vincent, Philippe Van der Linden, Maxime Cannesson, Joseph Rinehart
Joanna M. Shepherd, Jennifer Ross, Lourdes Anton, Claire Rourke, Adam R. Brentnall, Joel Tärning, Sir Nicholas White, Christoph Thiemermann, Karim Brohi
Discussion(0)
No comments yet. Be the first to comment.